🔗 Visit the ClinicalTrials.gov page for NCT02331368
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Promising therapies in multiple myeloma. | Blood | 2015 | 0.89 |
| 2 | Development of Novel Immunotherapies for Multiple Myeloma. | Int J Mol Sci | 2016 | 0.82 |
| 3 | Programmed death-1 checkpoint blockade in acute myeloid leukemia. | Expert Opin Biol Ther | 2015 | 0.79 |
| 4 | Targeting Intrinsic and Extrinsic Vulnerabilities for the Treatment of Multiple Myeloma. | J Cell Biochem | 2016 | 0.78 |
| 5 | The Role of Immunotherapy in Multiple Myeloma. | Pharmaceuticals (Basel) | 2016 | 0.77 |
| 6 | Fast Cars and No Brakes: Autologous Stem Cell Transplantation as a Platform for Novel Immunotherapies. | Biol Blood Marrow Transplant | 2015 | 0.76 |